Fucoxanthin is a major xanthophyll present in brown seaweeds such as Sargassum binderi, S. duplicatum, Turbinaria turbinata, Padina australis, Undaria pinnatifida and Hijkia fusiformis. This carotenoid has a unique structure including oxygenic functional group such as, two hydroxy, keto, epoxy (5,6-monoepoxide), and an allenic bond. Fucoxanthin has some anticancer activities such as inhibitory property on colon cancer cells and human hepatic carcinoma HepG2 cell line. This xanthophyll also induces apoptosis of human leukemia cancer HL-60 cells, human prostate cancer PC-3 cell, human lung cancer H1299 cell line etc. Unfortunately, the poor solubility of this carotenoid in water hinders it to be a drug candidate. Fucoxanthin is also a pigment that is sensitive to temperature and light. One of the possible ways to circumvent the problem with light and temperature is by microencapsulating it. Microencapsulation (ME) in biodegradable polymers, e.g. poly(D,L-lactic-co-glycolic acid) (PLGA) is a promising approach to protect any potential drug from rapid degradation. Solvent evaporation method is the most popular technique of preparing PLGA microsphere (MS) and this technique has been extensively studied in recent years for the preparation of MS. In the water-in-oil-in-water (w/o/w) double emulsion solvent evaporation method, stability of the primary emulsion (PE) is a critical factor. When the PE is unstable, encapsulation efficiency (EE) is low. Stability of PE can be enhanced by including emulsifying agent or stabilizers such as polyvinyl alcohol (PVA). The presence of a stabilizer/ emulsifier plays a significant role in influencing particle size (PS), external morphology of microsphere and colloidal stability.
Introduction
Fucoxanthin (3'-acetoxy-5,6-epoxy-3,5'-dihydroxy-6',7'-didehydro-5,6,7,8,5',6 '-hexahydro-β,β-caroten-8-on) is a major xanthophyll present in brown seaweed Koji & Hosokawa, 2013) . This compound contributes more than 10% of the estimated total production of carotenoids in nature (Matsuno, 2001; Miyashita, 2008) , especially in the marine ecosystem (Dembitsky & Maoka, 2007; Moghadamtousi et al., 2014) . It has a unique structure including oxygenic functional group, such as two hydroxy, keto, epoxy (5,6-monoepoxide), and an allenic bond in the molecule (Maeda et al., 2008; Miyashita, 2008; Riccioni et al., 2011; Kumar et al., 2013; Miyashita, 2014) . Its structure differs from that of common carotenoids (Ishikawa et al., 2008) such as β-carotene and lycopene (Tsukui et al., 2007) . The chemical structures of fucoxanthin and other epoxy xanthophylls are shown in Figure 1 . The sources of fucoxanthin from brown seaweeds are summarized in Table 1 .
Fucoxanthin and its Anticancer Activity
Fucoxanthin, a major carotenoid in brown seaweed (Das et al., 2008) exhibits inhibitory property on colon cancer cells, and this effect was associated with growth arrest (Das et al., 2008) , inhibited the growth of human hepatic carcinoma HepG2 cell line (Das et al., 2008) , and enhanced the antiproliferative effect of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone on colon cancer cells (Hosokawa, 2004) . Furthermore, fucoxanthin also induced apoptosis of human leukemia HL-60 cells (Kotake-Nara et al., 2005b) , human prostate cancer PC-3 cell line (Kotake-Nara et al., 2005a) , and human lung cancer H1299 cell line Noviendri, 2014 Noviendri et al., 2014a) (Figure 2 and 3).
The activity of fucoxanthin as anticancer agent is shown in Table 2 . In addition, fucoxanthin and its two metabolites, fucoxanthinol and halocynthiaxanthin have antioxidant activities. The proposed metabolic transformation of fucoxanthin to fucoxanthinol then finally converted to amarouciaxanthin A is shown in Figure 4 . This metabolic conversion was observed in mice and in human hepatoma cell HepG2 (Asai et al., 2004; Hashimoto et al., 2009 ).
Definition and the Main Reasons for Microencapsulation (ME)
ME has been defined as the technology of packaging or coating of solid, gaseous and liquid materials with a thin protective layer or wall material (McNamee et al., 1998) or in small capsules that release their contents at controlled rates over prolonged periods of time (Campagne & Fustier, 2007) . ME is a well-known technique that is used to delay and modify drug release from pharmaceutical dosage forms (Kim et al., 2002) . ME in biodegradable polymers, e.g. poly-(D,L-lactic-co-glycolic acid) (PLGA), was found to be a promising approach to protect the potential compounds from rapid degradation (Wischke & Borchert, 2006) . Moreover, a large number of ME techniques are available for the formation of sustained release (Wischke & Borchert, 2006) microparticulate drug delivery systems (Kim et al., 2002) . Furthermore, microparticles (MPs) or Figure 1 . Chemical structures of various epoxy xanthophylls (Redrawn from Kotake-Nara and Nagao, 2011).
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Techniques of ME
ME techniques are grouped into two basic categories, namely chemical and physical techniques, Figure 4 . Proposed metabolic transformation of dietary fucoxanthin in mammals (Redrawn from: Sugawara et al., 2002; Asai et al., 2004; Maoka, 2011; Kotake-Nara & Nagao, 2011; Miyashita, 2014; Moghadamtousi et al., 2014) .
Reason for ME technique References
To protect the sensitive compounds from the external environment factors such as moisture, oxygen, heat or light. Jyothi et al., 2010; Shekhar et al., 2010; Singh et al., 2010; Ahmad et al., 2011. To mask the organoleptic properties like odor, taste and colour of the compounds. Dubey et al., 2009; Yoshizawa, 2004; Jyothi et al., 2010; Shekhar et al., 2010; Ahmad et al. 2011 .
To obtain controlled release of the substance of drug.
Jyothi et al., 2010.
For sustained or prolonged drug release. Dubey et al., 2009; Jyothi et al., 2010; Shekhar et al., 2010. To modify and retard drug release. Naha et al., 2008 For safe handling of the toxic materials. Carrasquillo et al., 2001; Jyothi et al., 2010 .
To get targeted release of the drug. Dubey et al., 2009; Jyothi et al., 2010 .
To minimise negative effects like gastric irritation of the drug. Jyothi et al., 2010; Shekhar et al., 2010 . Table 3 . The advantages of ME technique with the latter being further subdivided into physicomechanical and physico-chemical techniques (Table  4) (Ghosh, 2006 spray drying ( Figure 5) (Manca, 2009 ). However, Mainardes and Evangelista (2005) reported the most commonly used ME technique is based on the concept of solvent and employs methylene chloride or dichloromethane (DCM) (Ansary et al., 2014) and water as disperse and continuous phase, respectively, in an emulsion type system.
Water-in-oil-in-water (w/o/w) Double Emulsion Solvent Evaporation Technique
Jaraswekin et al., (2007) , and Sahoo et al., (2011) have reported that solvent evaporation method is the most popular technique of preparing PLGA MSs or MPs. This method does not require phase separation inducing agents or elevated temperatures (Freitas et al., 2005; Emami, 2009) , and ME could also be easily scaled up to produce sterile microcapsules (Emami, 2009 ). Depending on the state of drug in the dispersion medium and the polymer solution, this method can be further classified into w/o/w double emulsion, waterin-oil (w/o) and oil-in-water (o/w) methods (Manca, 2009 ). Then, from several available methods, the w/o/ w double emulsion solvent evaporation is the most widely used method for preparation of MSs (Chaudari et al., 2010) .
The technique of ME by emulsion solvent evaporation removal technique has been applied extensively in pharmaceutical industries to obtain the controlled release of drug (Li et al., 2008) , protection of the drugs from degradation, and protection of the body from the negative effects of the drugs (Obeidat, 2009 ). This method has been widely used to prepare MSs loaded with various drugs, especially hydrophobic drugs (Yeo et al., 2001) . Moreover, because of their encapsulation and protection efficiency, w/o/w double emulsions solvent evaporation are potentially suitable materials for applications in various domains such as cosmetics, pharmaceutics, and foods (Bonnet et al., 2010) .
In the w/o/w double emulsion solvent evaporation method (Figure 6 ), stability of the primary emulsion (PE) is a critical factor for efficient internalization of the active ingredient (Maa & Hsu, 1997) . When the PE is unstable, encapsulation efficiency (EE) is low. Stability of PE can be enhanced by including emulsifying agent or stabilizers such as polyvinyl alcohol (PVA) (Yang et al., 2001) , Tween-80, or Span-80 (Li et al., 2008) . The presence of a stabilizer/ emulsifier (Mu & Feng, 2003) plays a significant role in influencing particle size (PS), external morphology of microsphere (Noviendri, 2014) (Figure 7) , and colloidal stability (Karata et al., 2009 ).
Biodegradable polymers for Microspheres (MSs)
Polymers used in ME are of two types (Alagusundaram et al., 2009) , namely synthetic polymers and natural polymers. The synthetic polymers are divided into two types: (a) nonbiodegradable polymers e.g. epoxy polymers, acrolein and glycidyl methacrylate, (b) biodegradable polymers e.g. lactides, glycolides and their copolymer poly anhydrides, poly-(ortho esters) and polyesters such as PLGA, and others. Natural polymers are obtained from different sources like, carbohydrate, chemically modified carbohydrate and chemically modified protein, such as hyaluronic acid, chitosan and alginic acid (Figure 8 ).
Among the different classes of biodegradable polymers, poly(lactide) (PLA) and PLGA are the most commonly used as drug carrier due to their biodegradability, mechanical strength (Athanasiou, 1996) , biocompatibility, and versatility in terms of physical, chemical and biological properties (Mohamed, 2008) . Furthermore, some of the requirements of biodegradable polymers can be summarized as follows (Llyod, 2002) : 1. The substance should have suitable processibility and permeability for the intended application. 2. The degradation time of the substance should match the healing. 3. The substance should not evoke a toxic response upon implantation in the body. 4.The substance should have acceptable shelf life.
The substance should have appropriate mechanical properties for the indicated application. The degradation products should be non-toxic, and able to get metabolized and cleared from the body.
Poly-(D, L-lactic-co-glycolic acid) (PLGA)
PLGA polymer is synthesized from homopolymer lactide and glycolide, respectively (Bouissou & Walle, 2006; Ansary et al., 2014) (Figure 9 ). PLGA polymer is most popular among the various synthetic Figure 7. A representative of particle size (PS) distribution of fucoxanthin-loaded microsphere (F-LM) by using a laser particle size analyser (LPSA) (A), and a representative of morphology of F-LM by using field emission-scanning electron microscope (FE-SEM) with magnification of 10,000X (B) (Noviendri, 2014; Noviendri et al., 2014b) . Figure 8 . Chemical structures of several biodegradable polymers (Park et al., 2005) . Figure 9 . Synthetic scheme of poly-(D, L-lactic-co-glycolic acid) (PLGA) (Ansary et al., 2014) .
biodegradable polymers (Varde & Pack, 2004) for pharmaceutical (Çirpanli et al., 2009 ) and biomedical applications (Emami et al., 2009) , because it has been approved by the United State Food and Drug Administration (US FDA) for clinical usage (Makadia & Siegel, 2011; Wang, 2012) , and biocompatibility (Cai et al., 2009; Çirpanli et al., 2009; Chaudhari et al., 2010) .
The use of biodegradable MSs or MPs as drug delivery system offers various advantages, such as: (i) the improvement of bioavailability (Barakat & Ahmad, 2008) , (ii) no need of (surgical) removal, (iii) easy administration (Siepmann et al., 2004) , (iv) the possibility to accurately control the release rate of an incorporated drug, (v) enhancement of stability and targeting a drug to specific sites (Barakat & Ahmad, 2008) , (vi) desire, pre-programmed drug release profile can be provided which matchs the therapeutic needs of the patients (Singh et al., 2010) , (vii) localized drug delivery and, (viii) high local drug concentration (Berkland et al., 2003) .
Biodegradation of PLGA
Among the families of synthetic polymers, PLGA have been attractive for pharmaceutical and medical applications because of their ease of degradation by hydrolysis of ester linkage (Gunatillake & Adhikari, 2003; Makadia & Siegel, 2011) . In addition, PLGA can be degraded into oligomeric and finally monomeric acids (Tsai, 2003; Siepmann et al., 2004; Makadia & Siegel, 2011) (Figure 10 ) including lactic acid and glycolic acid that are nontoxic to the human body (Torres-Lugo & Peppas, 2000) , and can be completely biodegraded into CO 2 and H 2 O (Yamaguchi et al., 2002) . Furthermore, in the human body, polyglycolides are broken down into glycine (amino acid) which can be excreted in the urine or converted into CO 2 and H 2 O via the citric acid cycle (Torres-Lugo & Peppas, 2000; Maurus & Kaeding, 2004; Mohamed, 2008) .
The rate of the PLGA biodegradation are dependent on the molecular weight (MW) of the polymer and the molar ratio of the glycolic and lactic acids in the polymer chain (Park, 1995) , the degree of crystallinity (Tracy et al., 1999) , and the glass transition temperature (Tg) of the polymer (Makadia & Siegel, 2011) . The Tg of the MSs increase with increasing MW of PLGA. However, the MS preparation was not found to affect the Tg of the polymer (Tsai, 2003) . The degradation rate of PLGA is inversely correlated to the crystallinity of the polymer since water does not penetrate easily into the crystalline regions (Tracy et al., 1999; Tsai, 2003) . PLGA, which is amorphous, will degrade faster than either of its semi-crystalline homo-polymers (DeLuca et al., 1993) . after 2 months (C) by using FE-SEM with magnification of 1500X (Noviendri, 2014; Jaswir et al., 2014) . Noviendri (2014) and Jaswir et al., (2014) have reported that electron micrograph of F-LM before incubation (control) showed spherical, discrete MSs with smooth surface ( Figure 11A ). The major changes in F-LM morphology were observed within 1 month, the F-LM had deformed, aggregated, fused and the F-LM morphologies had turned into an unstructured mass ( Figure 11B) . Finally, the F-LM were totally collapsed and disintegrated into irregular particles, and no intact spheres were observed ( Figure 11C ). The F-LM fabricated from PLGA (50/50) as coating needs 2 months for their degradation (Noviendri, 2014; Jaswir et al., 2014) . Wang (2012) reported that PLGA (50/ 50) polymer degraded in approximately 1 -2 months, PLGA 75/25 and PLGA 85/15 are degraded 4 -5 months and 5 -6 months, respectively.
Conclusion
Microencapsulation of fucoxanthin in biodegradable polymers, e.g. poly(D,L-lactic-co-glycolic acid) (PLGA) is a promising approach to protect fucoxanthin from the light, temperature, rapid degradation and to increase fucoxanthin solubility in the water. Solvent evaporation method is the most popular technique of preparing PLGA microsphere (MS) and this technique has been extensively studied in recent years for the preparation of fucoxanthin-loaded microsphere (F-LM). Because of their encapsulation and protection efficiency, w/o/w double emulsions solvent evaporation are potentially suitable materials for applications in various domains such as cosmetics, pharmaceutics, and foods. In the w/o/w double emulsion solvent evaporation method, stability of the primary emulsion (PE) is a critical factor for efficient internalization of the active ingredient. The F-LM fabricated from PLGA (50/50) as coating needs 2 months for their degradation. The F-LMs were totally collapsed and disintegrated into irregular particles, and no intact spheres were observed under field emission-scanning electron microscope (FE-SEM).
